Brief: Q Biomed Acquires Cancer Pain Drug Metastron From GE Healthcare
28/11/2018 13:07
Nov 28 (Reuters) - Q Biomed:
* Q BIOMED INC ANNOUNCES ACQUISITION OF CANCER PAIN DRUG
METASTRON
FROM GE HEALTHCARE
* DEAL FOR UNDISCLOSED UPFRONT PAYMENT, 1 MILESTONE PAYMENT
BASED
ON SALES & SINGLE DIGIT ROYALTY FOR 15 YRS
Source text for Eikon: ID:
Further company coverage: GE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Q BioMed
See all newsBrief: Q Biomed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office And Notice Of Allowance For Europe
Brief: Q Biomed Provides Shareholder Update
Brief: Q Biomed Announces Publication Of Research Showing Augmented Efficacy Of Its Drug Candidate Uttroside-B Against Liver Cancer
Brief: Q BioMed Inc Updates On COVID-19 Therapeutic Development And Clinical Trials
Brief: Q Biomed To Scale Up Production Of Uttroside-B